IGSF1 and Macroorchidism: Subsequently, the clinical features of patients with IGSF1 pathogenic variants have expanded and include delayed puberty, hypoprolactinemia, transient partial growth hormone (GH) deficiency, and increased body mass index (BMI), with or without macroorchidism [6].